semaglutide eligibility across all current indications for us adults 2026 Update: is now an approved medication cardiovascular diseases. It is recommended for the treatment of Type 2 diabetes and secondary prevention of cardiovascular complications in with established heart Semaglutide Eligibility Expands to Over

The result is sustained caloric deficit without the metabolic adaptation that makes dietary restriction alone so difficult to maintain long-term

Feeling cold on retatrutide is most likely due to loss of insulating body fat and reduced caloric intake, both of which lower the body's capacity to generate and retain heat

They can evaluate potential interactions and adjust your treatment plan accordingly to ensure your safety and optimise the effectiveness of your medications

A study by Xiao et al (2013) clearly associated people aged between 40-85 years old following long-term diets high in animal proteins (a rich source of methionine) with a higher risk of hyperhomocysteinemia, the reverse being true for diets that include a high consumption of plant foods (Xiao et al, 2013)